JMKX-003002

N/A

Report date: 2024/10/21 20:00:47
NME

Base Information

Drug NameJMKX-003002
Drug Alias NameJMKX-003002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperphosphatemiaKidney Failure, ChronicNephrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangxi Jemincare Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Hangyu Pharmaceutical Co LtdShanghai Jiyu Pharmaceutical Technology Co LtdJiangxi Jemincare Group Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsHyperphosphatemiaKidney Failure, ChronicNephrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A